Early Intervention for MS: Why the Gut Could Hold the Key
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
Early Intervention for MS: Why the Gut Could Hold the Key
-
Narrated by:
-
Written by:
About this listen
Multiple sclerosis (MS) is far more than a neurological disease, and emerging science shows the gut may play a larger role than anyone expected.
In this episode of Biome Breakthrough, Dr. Shaina Cahill and Jason Klop discuss how gut dysbiosis, chronic inflammation, immune imbalance, and microbiome disruption may contribute to MS progression, symptom severity, and long-term outcomes.
They explore:
- Why MS involves the gut, immune system, and brain
- How leaky gut, altered barrier integrity, and inflammation can activate microglia in the CNS
- The striking consistency of microbiome abnormalities in MS
- Why early intervention could dramatically change long-term outcomes
- Real patient stories showing rapid neurological and emotional improvements
- The surprising results from early FMT studies in MS
- How future medicine may use the microbiome as both a biomarker and a therapeutic
It highlights why the gut microbiome is rapidly becoming a central focus in research on neurodegenerative and autoimmune diseases.
Want to learn more or collaborate on clinical cases or research?
Connect with us at Novel Biome:
Email: support@novelbiome.com
Visit: www.novelbiome.com
Subscribe for more episodes exploring the microbiome, chronic disease, and the future of FMT.